Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study

MLA

Balbir Singh, et al. “Cardioverter-Defibrillator Reduces Mortality Risk in Eligible Ischemic and Non-Ischemic Cardiomyopathy Patients: Sub-Analysis of the Multi-Center Improve SCA Study.” Indian Heart Journal, vol. 75, no. 2, Mar. 2023, pp. 115–21. EBSCOhost, https://doi.org/10.1016/j.ihj.2023.01.010.

APA

Balbir Singh, Yu-Cheng Hsieh, Yen-Bin Liu, Kuo-Hung Lin, Boyoung Joung, Diego A. Rodriguez, Alexandr R. Chasnoits, Dejia Huang, Shu Zhang, Janet E. O’Brien, Daniel R. Lexcen, Jeffrey Cerkvenik, Brian Van Dorn, & Chi-Keong Ching. (2023). Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study. Indian Heart Journal, 75(2), 115–121. https://doi.org/10.1016/j.ihj.2023.01.010

Chicago

Balbir Singh, Yu-Cheng Hsieh, Yen-Bin Liu, Kuo-Hung Lin, Boyoung Joung, Diego A. Rodriguez, Alexandr R. Chasnoits, et al. 2023. “Cardioverter-Defibrillator Reduces Mortality Risk in Eligible Ischemic and Non-Ischemic Cardiomyopathy Patients: Sub-Analysis of the Multi-Center Improve SCA Study.” Indian Heart Journal 75 (2): 115–21. doi:10.1016/j.ihj.2023.01.010.